Enzene’s pioneering Fully-Connected Continuous Manufacturing™ platformBuilt on the company’s proven EnzeneX® fully‑connected continuous manufacturing™ (FCCM™) platform, NeX delivers a turnkey, scalable, and sustainable way to make state-of-the-art innovation in biologics manufacturing transportable, close to patients and supply chains, and without the prohibitive capital burden of conventional fed‑batch facilities. By enabling local FCCM‑based manufacturing, governments can significantly expand patient affordability and access to life‑saving biologics. “With our fully-connected continuous manufacturing platform, the same output can be achieved for $60–$80 million. Enzene’s NeX program is intended to help regions accelerate the establishment of local biopharma capabilities and risk-mitigated supply chains, develop domestic scientific talent, and reduce long-term manufacturing costs for local patients. NeX provides comprehensive facility design guidance, technology and IP transfer, workforce development through its SparX™ training program, operational oversight, and territory‑specific pipeline support.